No Data
No Data
Results of Adaptimmune's SPEARHEAD-1 Trial With Afami-cel in Advanced Sarcomas Published in the Lancet
Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - March 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining the treatment of solid tumor cancers with c
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading
European equities traded in the US as American depositary receipts were trending slightly higher late Wednesday morning, rising 0.18% to 1,370.27 on the S&P Europe Select ADR Index. From continental E
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading
European equities traded in the US as American depositary receipts opened the week trending higher late Monday morning, rising 0.62% to 1,375.76 on the S&P Europe Select ADR Index. From continental Eu
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Friday Trading
European equities traded in the US as American depositary receipts were trending higher Friday morning, advancing marginally to 1,368.34 on the S&P Europe Select ADR Index. From continental Europe, th
European Equities Traded in the US as American Depositary Receipts Ease Wednesday
European equities traded in the US as American depositary receipts eased Wednesday morning, dropping 0.3% to 1,351.185 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
European equities traded in the US as American depositary receipts were tracking moderately lower Thursday morning, falling 0.75% to 1,362.82 on the S&P Europe Select ADR Index. From continental Europ
No Data